Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-19-000736
Filing Date
2019-05-08
Accepted
2019-05-08 20:09:13
Documents
2
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2895
2 poamorrison.htm EX-24 7618
  Complete submission text file 0001123292-19-000736.txt   11897
Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Morrison Briggs (Reporting) CIK: 0001654430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 19808417

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations